CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Galderma Laboratories LP v. Actavis Laboratories UT Inc.

1:15-cv-00232

Overview

Case Number 1:15-cv-00232
Filing Date 2015-03-12
Status Terminated
Termination Date 2017-01-05
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Respondent

Novum Pharmaceutical Research Services Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Counter Claimant

Actavis Laboratories UT Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Counter Defendant

Nestle Skin Health S.A. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Galderma Laboratories LP NPE (Individual / Inventor)

Represented By

0 Attorneys Listed
No attorneys available

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 25 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (25): πŸ‡¨πŸ‡¦ Canada CN πŸ‡ͺπŸ‡Ί Europe πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

5 Patents

There are 5 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7439241
Compounds, formulations, and methods for treating or preventing rosacea
Filed: 2004-05-25
Issued: 2008-10-21
Expired (Term Ended) +457d PTA
Expires: 2025-08-25
US8410102
Methods and compositions for treating or preventing erythema
Filed: 2011-03-25
Issued: 2013-04-02
Expired (Term Ended)
Expires: 2024-10-23
US8426410
Compounds, formulations, and methods for treating or preventing inflammatory skin disorders
Filed: 2009-08-21
Issued: 2013-04-23
Expired (Term Ended)
Expires: 2024-09-10
US8859551
Compounds, formulations, and methods for treating or preventing inflammatory skin disorders
Filed: 2013-02-25
Issued: 2014-10-14
Expired (Term Ended)
Expires: 2025-01-10
US8513247
Methods and compositions for safe and effective treatment of erythema
Filed: 2011-03-25
Issued: 2013-08-20
Active (4.3 yrs remaining)
Expires: 2031-03-25

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+457 days) / In re Cellect scrutiny applies.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

2

Dispositive

0

Granted

0

Denied

0

Pending / Review

2

Motions by Category

Procedural / Extension Motion 2

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending / Under Review
Joint STIPULATION TO EXTEND TIME to Submit a Proposed Protective Order to October 7, 2015 - filed by Actavis Laboratories UT Inc.. (Vrana, Robert) (Entered: 09/...
Entry #20 • 2015-09-30 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to the Complaint to May 4, 2015 - filed by Actavis Laboratories UT Inc.. (Sharp, Melanie) (Ente...
Entry #8 • 2015-03-31 Document →

Docket Entries

(20 total)
Pleading / Complaint

COMPLAINT filed against Actavis Laboratories UT Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1690028.) - filed by Galderma Laboratories LP. (Attachments: # 1 Exhibit A-F, # 2 Civil Cover Sheet)(els) (Entered: 03/13/2015)

Entry #1 • 2015-03-12
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (els) (Entered: 03/13/2015)

Entry #2 • 2015-03-12
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 2/3/15. Date of Expiration of Patent: 8/25/25, 5/24/25, 3/25/13.Thirty Month Stay Deadline: 8/3/2017. (els) (Entered: 03/13/2015)

Entry #3 • 2015-03-12
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,439,241 B2; 8,410,102 B2; 8,426,410 B2; 8,859,551 B2; 8,513,247 B2;. (els) (Entered: 03/13/2015)

Entry #4 • 2015-03-12
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Galderma Laboratories, Inc. for Galderma Laboratories LP filed by Galderma Laboratories LP. (Blumenfeld, Jack) (Entered: 03/13/2015)

Entry #5 • 2015-03-13
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc